With biotech venture funding down 40% from peak levels and investor selectivity at historic highs, operational expertise has become the...
Biotech
LA JOLLA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
Sponsored content brought to you by When developing novel life science products, developers may face challenges in areas such...
On September 30, 2024, Highbridge Capital Management LLC, a prominent New York-based hedge fund, executed a significant transaction by acquiring...
